Deep expertise in intellectual property to support company’s innovations.
Deerfield Partner Andrew ElBardissi, M.D. and Petrichor Partner Patrick Lally to join Aurion Biotech board.
World-renowned ophthalmologists to support innovation of advanced therapies to treat ocular diseases.
Experienced industry executive to lead global regulatory initiatives.
Leading ophthalmology researcher, surgeon and inventor of corneal endothelial cell therapy will support the product’s clinical development.
Ophthalmologist to lead clinical development of advanced therapies to treat ocular diseases.
The company is developing a cell therapy for corneal endothelial disease.
Get the most important news and business ideas for eyecare professionals every weekday from INVISION.